These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 23093613)

  • 61. Intravenous thrombolysis for acute ischemic stroke occurring during hospitalization for transient ischemic attack.
    Tsivgoulis G; Sharma VK; Mikulik R; Krogias C; Haršány M; Bavarsad Shahripour R; Athanasiadis D; Teoh HL; Piperidou C; Alexandrov AV
    Int J Stroke; 2014 Jun; 9(4):413-8. PubMed ID: 23981541
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Factors predicting outcome in stroke patients treated with 0.6 mg/kg alteplase: evidence from the Japan Alteplase Clinical Trial (J-ACT).
    Mori E; Minematsu K; Nakagawara J; Yamaguchi T;
    J Stroke Cerebrovasc Dis; 2011 Nov; 20(6):517-22. PubMed ID: 20719535
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Clinical and magnetic resonance imaging predictors of very early neurological response to intravenous thrombolysis in patients with middle cerebral artery occlusion.
    Apoil M; Turc G; Tisserand M; Calvet D; Naggara O; Domigo V; Baron JC; Oppenheim C; Touzé E
    J Am Heart Assoc; 2013 Dec; 2(6):e000511. PubMed ID: 24308937
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Outcome of patients with negative CT angiography results for arterial occlusion treated with intravenous thrombolysis.
    Mikulik R; Goldemund D; Reif M; Aulicky P; Krupa P
    Stroke; 2009 Mar; 40(3):868-72. PubMed ID: 19131650
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Safety and outcomes of intravenous thrombolysis in stroke mimics: a 6-year, single-care center study and a pooled analysis of reported series.
    Tsivgoulis G; Alexandrov AV; Chang J; Sharma VK; Hoover SL; Lao AY; Liu W; Stamboulis E; Alexandrov AW; Malkoff MD; Frey JL
    Stroke; 2011 Jun; 42(6):1771-4. PubMed ID: 21493900
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Feasibility and safety of magnetic resonance imaging-based thrombolysis in patients with stroke on awakening: initial single-centre experience.
    Breuer L; Schellinger PD; Huttner HB; Halwachs R; Engelhorn T; Doerfler A; Köhrmann M
    Int J Stroke; 2010 Apr; 5(2):68-73. PubMed ID: 20446939
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Thrombolysis With Alteplase at 0.6 mg/kg for Stroke With Unknown Time of Onset: A Randomized Controlled Trial.
    Koga M; Yamamoto H; Inoue M; Asakura K; Aoki J; Hamasaki T; Kanzawa T; Kondo R; Ohtaki M; Itabashi R; Kamiyama K; Iwama T; Nakase T; Yakushiji Y; Igarashi S; Nagakane Y; Takizawa S; Okada Y; Doijiri R; Tsujino A; Ito Y; Ohnishi H; Inoue T; Takagi Y; Hasegawa Y; Shiokawa Y; Sakai N; Osaki M; Uesaka Y; Yoshimura S; Urabe T; Ueda T; Ihara M; Kitazono T; Sasaki M; Oita A; Yoshimura S; Fukuda-Doi M; Miwa K; Kimura K; Minematsu K; Toyoda K;
    Stroke; 2020 May; 51(5):1530-1538. PubMed ID: 32248771
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Worse stroke outcome in atrial fibrillation is explained by more severe hypoperfusion, infarct growth, and hemorrhagic transformation.
    Tu HT; Campbell BC; Christensen S; Desmond PM; De Silva DA; Parsons MW; Churilov L; Lansberg MG; Mlynash M; Olivot JM; Straka M; Bammer R; Albers GW; Donnan GA; Davis SM;
    Int J Stroke; 2015 Jun; 10(4):534-40. PubMed ID: 23489996
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Immediate changes in stroke lesion volumes post thrombolysis predict clinical outcome.
    Luby M; Warach SJ; Nadareishvili Z; Merino JG
    Stroke; 2014 Nov; 45(11):3275-9. PubMed ID: 25213340
    [TBL] [Abstract][Full Text] [Related]  

  • 70. End-diastolic velocity increase predicts recanalization and neurological improvement in patients with ischemic stroke with proximal arterial occlusions receiving reperfusion therapies.
    Alexandrov AV; Tsivgoulis G; Rubiera M; Vadikolias K; Stamboulis E; Molina CA; Alexandrov AW;
    Stroke; 2010 May; 41(5):948-52. PubMed ID: 20224054
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The presence of a right-to-left shunt is associated with dramatic improvement after thrombolytic therapy in patients with acute ischemic stroke.
    Kimura K; Iguchi Y; Shibazaki K; Terasawa Y; Aoki J; Matsumoto N
    Stroke; 2009 Jan; 40(1):303-5. PubMed ID: 18845803
    [TBL] [Abstract][Full Text] [Related]  

  • 72. THrombolysis for Acute Wake-up and unclear-onset Strokes with alteplase at 0·6 mg/kg (THAWS) Trial.
    Koga M; Toyoda K; Kimura K; Yamamoto H; Sasaki M; Hamasaki T; Kitazono T; Aoki J; Seki K; Homma K; Sato S; Minematsu K;
    Int J Stroke; 2014 Dec; 9(8):1117-24. PubMed ID: 25088843
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Outcomes of a contemporary cohort of 536 consecutive patients with acute ischemic stroke treated with endovascular therapy.
    Abilleira S; Cardona P; Ribó M; Millán M; Obach V; Roquer J; Cánovas D; Martí-Fàbregas J; Rubio F; Alvarez-Sabín J; Dávalos A; Chamorro A; de Miquel MA; Tomasello A; Castaño C; Macho JM; Ribera A; Gallofré M;
    Stroke; 2014 Apr; 45(4):1046-52. PubMed ID: 24595590
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Total mismatch: negative diffusion-weighted imaging but extensive perfusion defect in acute stroke.
    Cho TH; Hermier M; Alawneh JA; Ritzenthaler T; Desestret V; Østergaard L; Derex L; Baron JC; Nighoghossian N
    Stroke; 2009 Oct; 40(10):3400-2. PubMed ID: 19696413
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Elderly patients are at higher risk for poor outcomes after intra-arterial therapy.
    Chandra RV; Leslie-Mazwi TM; Oh DC; Chaudhry ZA; Mehta BP; Rost NS; Rabinov JD; Hirsch JA; González RG; Schwamm LH; Yoo AJ
    Stroke; 2012 Sep; 43(9):2356-61. PubMed ID: 22744644
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Assessing reperfusion and recanalization as markers of clinical outcomes after intravenous thrombolysis in the echoplanar imaging thrombolytic evaluation trial (EPITHET).
    De Silva DA; Fink JN; Christensen S; Ebinger M; Bladin C; Levi CR; Parsons M; Butcher K; Barber PA; Donnan GA; Davis SM;
    Stroke; 2009 Aug; 40(8):2872-4. PubMed ID: 19478228
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset.
    Furlan AJ; Eyding D; Albers GW; Al-Rawi Y; Lees KR; Rowley HA; Sachara C; Soehngen M; Warach S; Hacke W;
    Stroke; 2006 May; 37(5):1227-31. PubMed ID: 16574922
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Elevations in Tissue Fluid-Attenuated Inversion Recovery Signal Are Related to Good Functional Outcome after Thrombolytic Treatment.
    Tanriverdi Z; Gocmen R; Oguz KK; Topcuoglu MA; Arsava EM
    J Stroke Cerebrovasc Dis; 2016 Feb; 25(2):480-3. PubMed ID: 26652209
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Low body temperature does not compromise the treatment effect of alteplase.
    Lees JS; Mishra NK; Saini M; Lyden PD; Shuaib A;
    Stroke; 2011 Sep; 42(9):2618-21. PubMed ID: 21757664
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Treating ischaemic stroke with intravenous tPA beyond 4.5 hours under the guidance of a MRI DWI/T2WI mismatch was safe and effective.
    Bai QK; Zhao ZG; Lu LJ; Shen J; Zhang JY; Sui HJ; Xie XH; Chen J; Yang J; Chen CR
    Stroke Vasc Neurol; 2019 Mar; 4(1):8-13. PubMed ID: 31105973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.